Incorporation of fatty acids into phospholipids has been investigated using samples of rat liver tissue homogenate, Krebs-Ringer-phosphate buffer (pH = 7.4) containing 0.3% albumin, fatty acid mixture a nd glyceroL The addition of L-kynurenine (4 nmol/g wet weight), D-eryhro-neopterin (5 and 30 pmol/g wet weight) and noradrenaline (4 nmol/g wet weight) to incuhation medium induced an increase of saturated (palmitic acid) and decrease of poly-unsaturated (linoleic and arachidonic acid) fatty acids incorporation into phospholipids. The increase of saturated fatty acids incorporation into phospholipids was more pronounced after addition of neopterin and noradrenaline to the incubation medium while the decrease of linoleic and arachidonic acid synthesis was stimulated most with kynurenine. Moreover, kynurenine stimulated whereas neopterin depressed the oleic acid incorporation into phospholipids. These changes of fatty acid incorporation into phospholipids were followed by increase of cholesterol content in samples containing kynurenine, neopteri n or noradrenalin. In contrast, phospholipid content decreased in samples containing kynurenine or noradrenalin, hut was not altered by supplementation of neopterin. Since the addition of kynurenine and neopterin to incubation medium for isolated fog heart resulted in an increased noradrenaline and decreased pyridoxal-5-phosphate content in the tissue, we also added pyridoxal-5-phosphate (4 nmol/g wet weight) to incubation medium for phospholipid biosy nthesis. No change of the fatty acid incorporation into phospholipids as welI as the contcnt of phospholipids and cholesterol in sa mples was observed.
Introduction
Activation of the immune system is associated with the release of specific cytokines which regulate and direct the interaction between immune celIs (I). Among them interferon-gamma is a specific product of stimulated T-Iymphocytes which primes monocyte/ macrophage for cytotoxicity. In human monocytes/ macrophages interferon-gamma also induces GTP-cyclohydrolase I, which is the key-enzyme for § Author to whom correspondence should he add ressed.
Pteridines / Vol. 4 / No.3 the biosynthesis of pteridines such as 5,6,7,8-tetrahydro-biopterin and neopterin, and indoleamine (23)-dioxygenase, which cleaves tryptophan to form Nformyl-kynurenine (2) . In vivo, increased neopterin concentrations and degradation of tryptoph an is preferentially observed in patients suffering from diseases known to be associated with immune activation such as alIograft rejection, virus infections, autoimmune disorders and certain types of cancer (3) (4) (5) (6) . Recently increased serum concentrations of neopterin and kynurenine have been observed in patients with congestive hea rt failure (7, 8) . Abnormali-ties of left ventricle functional tests correlated with the degree of neopterin and kynurenine changes.
In vitro, L-kynurenine, D-erythro-neopterin and noradrenalin were previously reported to induce heart cell injury (9-11). Kynurenine also changes lipid metabolism due to impairment of phospholipid biosynthesis and fatty acid incorporation into phospholipids (12) . The aim of this study was to examine possible effects of kynurenine and neopterin on the content of noradrenaline and pyridoxal-S-phosphate (P-S-P) in tissue and to investigate the influence of kynurenine, neopterin, noradrenaline and P-S-P on cholesterol content and phospholipid biosynthesis of isolated frog heart in vitro.
Methods
Isolatcd frog hearts of 20 frogs in winter were used to examine possible effects of kynurenine and neopterin on noradrenaline and P-S-P content in tissue. We added IO Ilmol/l of L-kynurenine sulphate (SE-RVA Munich, Germany) or 20 nmol/l of D-erythroneopterin (Schircks-Laboratories, 10na, Switzerland) to the incubation medium for cold blooded animals. After 30 min. incubation at room temperature the contents of noradrenaline and P-S-P in tissue were determined (13, 14) .
Homogenized liver tissue of 16 male white Wistar rats were used for determination of biosynthesis according to a previously described method (IS). The liver was promptly removed from a decapitated animal and 2.0 g of it were homogenized in 16 ml of Krebs-Ringer-phosphate buffer. Samples were incubated at 37°C for 4 hours. To each test-tube 60 III of 20% fatty acid solution in chloroform (stearic. palmitic, oleic and arachidonic acid in equivalent amount, SIGMA) and 40 IJl of glycerol were added. All test-tubes were incubated at 3rC for another 4 hours. After this second incubation, 75 ml of a chloroform:methanol mixture (2:1) were added to each sample. The samples were mixed and left for 40 min at room temperature. Then the chloroform-methanol extract was filtered and the filtrate was carefully treated according to the method of Folch and others (16) . Kynurenine sulphate (4.0 nmol/g wet weight) or neopterin (S.O pmol/g and 30 pmol/g wet weight) or noredrenaline (4 nmol/g wet weight, SERVA). or P-S-P (4 nmol/g wet weight. SERVA) were added to experimental test-tubes before the first incubation in· order to investigate possible effects of these substances on this process. All mentioned meta bolites were diluted in bidestilled water. The same volume (0.1 ml) of bidestilled water without metabolite was added to control test-tubes before the first incubation. The whole cholesterol concentration was determined by the method of Engelhardt and Smimova (17) which is a modification of a conventional Liebermann-Burchardt's method and involves the following steps: the hydrolysis of esters with potassium hydroxide, double cholesterol extraction with chloroform followed by colour formation with acetic anhydride and sulphuric acid. The concentration of the obtained coloured product was measured photometrically at 625 nm wavelength. For its quantitative estimation a standard cholesterol solution of 100 mg% concentration was used (SERVA). The method enables to determine cholesterol in the range from 20 to 400 mg% without additional concentration or dilution steps. The recovery of cholesterol added to the samples constitutes 96%.
The amount of phospholipids was determined by the method of Urbach-Raabe, which is based on the determination of inorganic phosphorus (18) . The lipids extracted by the method of Folch and others were evaporated. The mineralization of dry lipid residue was performed by sa turated ammonium-molybdate solution in concentrated perchloric acid. After mineralization the samples were boiled with 3.0 ml of distilled water fo 3 minutes to destroy the polyphosphoric acids. After cooling at room temperature, 0.5 ml of 2% hydrochinone and O.S ml of extempore prepared reagent (10% aqueous ammonium-molybdate solution and 2 ammonium sulphate in equal a mount) were added to each sample, so that the inorganic phosphorus formed a blue-coloured complex with hydrochinone ammonium-molybdate. The sa mples were diluted to IO m1 by aqueous solution of 44.0 g N a 2 C O " and 10.0 g Na2So., per liter. The colour intensity was measured spectrophotometricalIy at 6S0 nm wavelength. The linearity range of · the method is from 10 mg% to 300 mg%. recovery is 98%.
The method of Kates (19) was used to prepare the phospholipid samples for fatty acid content examination. The dry lipid residue obtained by the method of Folch and coworkers (16) was treated twice with ice-cold aceton and magnesium chloride solution (0.1 ml I m MgCl2 in 4.0 ml of aceton), which precIpItates 97% of total phospholipid amount. Then the phospholipid saponification with 4% of sodium hydroxide solution in methanole:benzene (2:1) was performed. Thereafter the methylation catalyst (0.2 ml of concentrated perchloric acid) was added to complete the process of ester formation. This step was followed by ester extraction with hexane and vacuum-evaporation of hexane at 4SO C. Then methylesters of fatty acids were ready for gas chromatography by a conventional technique for fatty acid methylesters: helium was used as carrier gas, and the sorbent was chromasorb covered with DEAG. Separated fatty acid methyiesters were monitored at 2Wt, using flame ionization detection.
The separation was controlled with internal methylester standard substances (SERVA). The error of measurement for one and the same sample differed from 2.8% to 15.0% for the fatty acid examined.
Statistical analyses were done using Student's ttest. P-values below 0.05 were considered to indicate significant differences.
Results
Fig . I shows the changes of noradrenaline concentrations of isolated heart tissue after addition of kynurenine or neopterin to incubation medium, an increase of noradrenaline content in the tissue was observed in both cases (p<O.OOl). Under these conditions the amount of P-5-P decreased (see Fig. 2 ) in heart tissue (p<O.OI). Both effects were more expressed for addition of neopterin than for kynurenme. Fig. 3 points out the changes of phospholipid biosynthesis after addition of kynurenine to samples. We observed an increase of palmitic acid incorporation (p<O.OOI) and a decrease of linoleic and arachidonic incorporation (p<0.05-p<0.00l) into phospholipids. Moreover. kynurenine promoted the process of oleic acid incorporation into phospholipids (p<O.OOI). At time of biosynthesis the amount of phospholipids decreased (p<O.OI). while the amount of cholesterol increased (p<O.OOI) in samples containing kynurenine. Fig. 4 shows the changes of phospholipid biosynthesis after addition of neopterin (5 and 30 pmol/g wet weight) to samples. With both concentrations investigated neopterin promotes palmitic acid incorporation into phospholipids (p<O.OOl) and reduces the incorporation of oleic, linoleic and arachidonic acid into phospholipid (p<O.OI-p<O.OOI). The cholesterol content increased in neopterin treated samples (p<O.OOl), while the amount of phospholipids was not altered. Fig. 5 pictures changes of phospholipid biosynthesis after addition of noradrenaline to samples. An increase of palmitic acid incorporation into phosphol ipids (p<O.OOI) and a decrease of linoleic and arachidonic acid incorporation into phospholipids was obsetved. The oleic acid incorporation into phospholipids was not altered. We obsetved an increase of cholesterol (p<O.OO I) and a decrease of phospholipids (p<O.OI) content in samples containing noradrenaline.
The effects of P -5-P on cholesterol and phospholipid countent as well as on th e process of fatty acid incorporation into phospholipids is demonstrated in F ig. 6. P-5-P did not alter cholesterol and phospholipid content and had no effect on the 111-corporation of fatty acids into phospholipids. Discussion P-5-P is necessary in the process of phosphatidylserine conversion to phosphatidylethanolam ine (20) . It is also of importance in homocystein metabolism (2 1), ' in wh ich methyl groups are liberated. These methyl groups are used for methylation, e.g .. for conversion of noradrenaline to adrenaline. Our rcsults obtained with isolated frog heart demostrate that the addition of kynurenine as well as of neopterin was followed by an increase of noradrenaline and decrease of P-5-P content in the tissue. Our result., further show that kynurenine as well as neopterin increased the cholesterol content in samples and influenced the process of fatty acid incorporation into phospholipids. Theses changes were similar to alterations induced by noradrenaline. In addition. kynurenine further increased incorporation of oleic acid. while D-neopterin and noradrenalin stimulated incorporation of saturated fatty acids.
The data suggest that the changes in phospholipid metabolism could be important in the pathogenesis of the deviation of cell membrane permeability. P-5-P did not show any effect on cholesterol and phospholipid content as well as on the process of fatty acid incorporation into phospholipids.
In patients with cardiac disorders such as congestive heart failure (7. lS) and in patients with acute rheumatic fever associated with the development of valve lesions (22) increased ncopterin concentrations have been described as wcll as in patients with atherosclerosis (23) . The data of this study may indicate that endogenously formed neopterin concentrations could be even pathogenetically involved in such diseases. One thc one hand neopterin is able to enhance radical-cytotoxic effects (24) which may contribute to thc development of coronary lesions. on the other hane!, increased neopterin concentrations may influence lipid metabolism whieh may further enhance the risk for the development of atherosclerosis. Additional studies are needed to clarily this point.
